Cargando…
Angiopoietin‐2 provides no incremental predictive value for the presence of obstructive coronary artery disease over N‐terminal pro‐brain natriuretic peptide
BACKGROUND: Using circulating biomarkers as a noninvasive method to assist the evaluation of coronary artery disease (CAD) is beneficial for reducing the unnecessary diagnostic cardiac catheterization. This study aimed to assess the predictive role of angiopoietin‐2 (Ang‐2) for the presence of obstr...
Autores principales: | Jian, Wen, Mo, Chang‐Hua, Yang, Guo‐Liang, Li, Lang, Gui, Chun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805287/ https://www.ncbi.nlm.nih.gov/pubmed/31257664 http://dx.doi.org/10.1002/jcla.22972 |
Ejemplares similares
-
N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015) -
Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015) -
Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014) -
Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease
por: Dallmeier, Dhayana, et al.
Publicado: (2015) -
N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)